Study Shows Potential for Treatment of Obsessive-Compulsive Disorder with Focused Ultrasound
By MedImaging International staff writers Posted on 05 Jan 2015 |
In the proof-of-concept study, Obsessive-Compulsive Disorder (OCD) patients that did not respond to other medical therapies for OCD (such as pharmacotherapy and cognitive-behavioral therapy) were treated with bilateral thermal capsulotomy using Magnetic Resonance-guided focused ultrasound (MrgFUS) to the anterior internal capsule of the brain.
The patients underwent comprehensive neuropsychological testing at baseline, one week, one month, and six months after treatment using the Yale–Brown Obsessive-Compulsive Scale (Y-BOCS), the Hamilton Rating Scale for Anxiety (HAM-A), and the Hamilton Rating Scale for Depression (HAM-D).
The results of the study in which four patients with disabling medically-refractory OCD were treated with focused ultrasound were published in the Journal of Molecular Psychiatry. The study was conducted by Jin Woo Chang, MD, PhD, at the Yonsei University Medical Center, Seoul, (Seoul, Korea).
The results showed that during the 6-month follow-up period Y-BOCS scores improved by 33%, anxiety decrease by an average of 69.4%, and all patients showed an average decrease of depression by 61.1%. The researchers did not find any physical or neuro-psychological side effects from the treatments.
Related Links:
Yonsei University Medical Center
The patients underwent comprehensive neuropsychological testing at baseline, one week, one month, and six months after treatment using the Yale–Brown Obsessive-Compulsive Scale (Y-BOCS), the Hamilton Rating Scale for Anxiety (HAM-A), and the Hamilton Rating Scale for Depression (HAM-D).
The results of the study in which four patients with disabling medically-refractory OCD were treated with focused ultrasound were published in the Journal of Molecular Psychiatry. The study was conducted by Jin Woo Chang, MD, PhD, at the Yonsei University Medical Center, Seoul, (Seoul, Korea).
The results showed that during the 6-month follow-up period Y-BOCS scores improved by 33%, anxiety decrease by an average of 69.4%, and all patients showed an average decrease of depression by 61.1%. The researchers did not find any physical or neuro-psychological side effects from the treatments.
Related Links:
Yonsei University Medical Center
Latest Ultrasound News
- Groundbreaking Technology Enables Precise, Automatic Measurement of Peripheral Blood Vessels
- Deep Learning Advances Super-Resolution Ultrasound Imaging
- Novel Ultrasound-Launched Targeted Nanoparticle Eliminates Biofilm and Bacterial Infection
- AI-Guided Ultrasound System Enables Rapid Assessments of DVT
- Focused Ultrasound Technique Gets Quality Assurance Protocol
- AI-Guided Handheld Ultrasound System Helps Capture Diagnostic-Quality Cardiac Images
- Non-Invasive Ultrasound Imaging Device Diagnoses Risk of Chronic Kidney Disease
- Wearable Ultrasound Platform Paves Way for 24/7 Blood Pressure Monitoring On the Wrist
- Diagnostic Ultrasound Enhancing Agent to Improve Image Quality in Pediatric Heart Patients
- AI Detects COVID-19 in Lung Ultrasound Images
- New Ultrasound Technology to Revolutionize Respiratory Disease Diagnoses
- Dynamic Contrast-Enhanced Ultrasound Highly Useful For Interventions
- Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis
- Artificial Intelligence Detects Heart Defects in Newborns from Ultrasound Images
- Ultrasound Imaging Technology Allows Doctors to Watch Spinal Cord Activity during Surgery
- Shape-Shifting Ultrasound Stickers Detect Post-Surgical Complications